Tiletamine-Zolazepam for Lemurs: Telazol Uses, Sedation & Recovery

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Tiletamine-zolazepam is an injectable veterinary anesthetic and sedative combination. Tiletamine is a dissociative anesthetic, while zolazepam is a benzodiazepine tranquilizer. Together, they help produce restraint, sedation, and short-term anesthesia. In veterinary medicine, this combination is commonly known by brand names such as Telazol or Zoletil.

For lemurs and other nonhuman primates, your vet may use tiletamine-zolazepam when safe handling is not possible with manual restraint alone. It is not a home medication and should only be given by trained veterinary professionals with monitoring equipment and a recovery plan in place.

Lemurs can respond differently from dogs and cats, and even different primate groups can have different dose ranges and recovery patterns. That is why your vet will tailor the protocol to your lemur's species, body condition, stress level, age, and the procedure being performed.

In lemurs, tiletamine-zolazepam is most often used for chemical restraint, short diagnostic procedures, transport-related sedation, and induction before gas anesthesia. It may be chosen for physical exams, wound care, blood collection, imaging, or other situations where movement would make handling unsafe for the animal or veterinary team.

In zoo and wildlife medicine, tiletamine-zolazepam is valued because it has a relatively rapid onset and can be delivered in a small injection volume. Merck Veterinary Manual notes that tiletamine-zolazepam may provide improved sedation for some primate species, and published field work in ring-tailed lemurs has described its use as part of combination protocols with medetomidine and butorphanol.

This drug is usually part of a broader anesthesia plan rather than a one-size-fits-all answer. Your vet may pair it with other medications to improve muscle relaxation, pain control, or recovery quality, or may choose a different protocol if your lemur has heart, lung, kidney, liver, or pregnancy-related concerns.

Dosing for lemurs is highly individualized and should be calculated only by your vet. Merck Veterinary Manual lists tiletamine-zolazepam doses for nonhuman primates by broad primate group rather than by every species. For New World primates, reported intramuscular doses are about 1 to 2.5 mg/kg once, while some other primates may require higher ranges. Lemurs are prosimians, not New World monkeys, so your vet should not assume a monkey dose automatically applies to a lemur.

Published field anesthesia work in ring-tailed lemurs has also described tiletamine-zolazepam as part of multi-drug immobilization protocols rather than as a stand-alone drug. In practice, your vet may adjust the dose downward when combining it with alpha-2 agonists or opioids, because combination protocols can deepen sedation and change recovery.

The reconstituted product contains 50 mg/mL of tiletamine and 50 mg/mL of zolazepam, for a combined concentration of 100 mg/mL. That concentration matters because even a small volume change can significantly alter the delivered dose in a small primate. Fasting plans, hydration status, body temperature support, airway management, and post-sedation monitoring are all part of safe dosing, not separate details.

Never estimate or repeat a previous dose at home. If a lemur seems too awake, too sleepy, or slow to recover after sedation, that is a veterinary monitoring issue and not something a pet parent should try to correct without immediate guidance from your vet.

Common concerns after tiletamine-zolazepam include prolonged grogginess, poor coordination, rough or dysphoric recovery, excess salivation, vomiting, and changes in breathing or heart rate. Merck notes that severe ataxia has been observed during recovery in some primates. In a lemur, that can translate into climbing risk, falls, panic, or self-injury if recovery housing is not quiet, warm, padded, and closely supervised.

Like other injectable anesthetic agents, tiletamine-zolazepam can affect the cardiovascular and respiratory systems. Recovery may be slower or less smooth if the lemur is stressed, dehydrated, hypothermic, or has underlying disease. Aspiration is also a concern in sedated primates if food or debris remains in the mouth when jaw tone decreases.

See your vet immediately if your lemur has labored breathing, blue or gray gums, repeated vomiting, collapse, seizures, severe agitation, inability to perch safely, or does not seem to be waking as expected. Even when the procedure itself is routine, recovery is the period when careful observation matters most.

Tiletamine-zolazepam is often intentionally combined with other sedatives or anesthetic drugs, but those combinations need planning and monitoring. Alpha-2 agonists such as medetomidine or dexmedetomidine, opioids such as butorphanol, inhalant anesthetics, and other injectable sedatives can all increase sedation depth and may change heart rate, blood pressure, breathing, and recovery time.

Product labeling and veterinary drug references warn against combining tiletamine-zolazepam casually with phenothiazine tranquilizers because the combination can increase risks such as respiratory depression, myocardial depression, hypotension, and hypothermia. Other central nervous system depressants may also intensify effects.

Your vet should know about every medication, supplement, and recent anesthetic your lemur has received, including pain medications, seizure drugs, antibiotics, and any prior sedation history. That helps your vet choose a protocol that fits the procedure, the lemur's medical status, and the type of monitoring available.